NCT03378336 Psoriatic Arthritis Research Collaborative: Biologic Sub-Study Status COMPLETED Phase N/A
NCT03374527 Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis Status COMPLETED Phase N/A
NCT03370133 A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03347110 A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT03336281 A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab Status COMPLETED Phase N/A
NCT03320876 An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis. Status TERMINATED Phase PHASE2
NCT03248518 Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases Status COMPLETED Phase NA
NCT03248284 Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons Status RECRUITING Phase N/A
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service Status COMPLETED Phase N/A
NCT03214263 Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases Status RECRUITING Phase N/A
NCT03152396 Pharmacist CVD Intervention for Patients With Inflammatory Arthritis Status UNKNOWN Phase NA
NCT03151551 A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT03148860 Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA Status COMPLETED Phase PHASE3
NCT03119805 Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective. Status COMPLETED Phase N/A
NCT03104400 A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) Status COMPLETED Phase PHASE3
NCT03104374 A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug Status COMPLETED Phase PHASE3
NCT03101670 A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT03058900 Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis Status COMPLETED Phase NA